×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
BCRX – biocryst pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
BCRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/6
06:09 am
bcrx
BioCryst Pharmaceuticals (BCRX) was upgraded by Weiss Ratings from "sell (d-)" to "hold (c)".
Neutral
Report
BioCryst Pharmaceuticals (BCRX) was upgraded by Weiss Ratings from "sell (d-)" to "hold (c)".
3/4
07:25 am
bcrx
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Low
Report
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
3/4
07:00 am
bcrx
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/2
04:43 am
bcrx
A Look At BioCryst Pharmaceuticals (BCRX) Valuation As Net Income Turns Positive And Astria Deal Expands HAE Portfolio [Yahoo! Finance]
Low
Report
A Look At BioCryst Pharmaceuticals (BCRX) Valuation As Net Income Turns Positive And Astria Deal Expands HAE Portfolio [Yahoo! Finance]
3/1
07:02 pm
bcrx
BioCryst's First Profitable Year Recasts Hereditary Angioedema Growth Story [Yahoo! Finance]
Low
Report
BioCryst's First Profitable Year Recasts Hereditary Angioedema Growth Story [Yahoo! Finance]
2/28
07:38 am
bcrx
BioCryst (BCRX) Soars 10.8% on Swing to Profits [Yahoo! Finance]
Low
Report
BioCryst (BCRX) Soars 10.8% on Swing to Profits [Yahoo! Finance]
2/27
12:00 am
bcrx
Where is BioCryst Pharmaceuticals (BCRX) Headed According to the Street? [Yahoo! Finance]
High
Report
Where is BioCryst Pharmaceuticals (BCRX) Headed According to the Street? [Yahoo! Finance]
2/26
04:42 pm
bcrx
BioCryst Pharmaceuticals Inc (BCRX) Q4 2025 Earnings Call Highlights: Record Profitability and ... [Yahoo! Finance]
High
Report
BioCryst Pharmaceuticals Inc (BCRX) Q4 2025 Earnings Call Highlights: Record Profitability and ... [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
2/26/2026
07:00 am
BCRX
biocryst pharmaceuticals, inc.
BEAT
Report
0.9%
biocryst pharmaceuticals, inc.
11/3/2025
07:00 am
BCRX
biocryst pharmaceuticals, inc.
BEAT
Report
-3.2%
biocryst pharmaceuticals, inc.
8/4/2025
07:00 am
BCRX
biocryst pharmaceuticals, inc.
BEAT
Report
3.9%
biocryst pharmaceuticals, inc.
5/5/2025
07:00 am
BCRX
biocryst pharmaceuticals, inc.
BEAT
Report
16.6%
biocryst pharmaceuticals, inc.
Date
Time
Symbol
Headline
Impact
3/3
04:41 pm
bcrx
Form 4 BIOCRYST PHARMACEUTICALS For: Feb 27 Filed by: Milne Jill C.
Low
Report
Form 4 BIOCRYST PHARMACEUTICALS For: Feb 27 Filed by: Milne Jill C.
3/3
04:39 pm
bcrx
Form 4 BIOCRYST PHARMACEUTICALS For: Feb 27 Filed by: Stonehouse Jon P
Low
Report
Form 4 BIOCRYST PHARMACEUTICALS For: Feb 27 Filed by: Stonehouse Jon P
3/3
04:36 pm
bcrx
Form 4 BIOCRYST PHARMACEUTICALS For: Feb 27 Filed by: MILANO VINCENT
Low
Report
Form 4 BIOCRYST PHARMACEUTICALS For: Feb 27 Filed by: MILANO VINCENT
3/3
04:33 pm
bcrx
Form 4 BIOCRYST PHARMACEUTICALS For: Feb 27 Filed by: Frank Steven
Low
Report
Form 4 BIOCRYST PHARMACEUTICALS For: Feb 27 Filed by: Frank Steven
3/3
04:29 pm
bcrx
Form 4 BIOCRYST PHARMACEUTICALS For: Feb 27 Filed by: McKee Amy E
Low
Report
Form 4 BIOCRYST PHARMACEUTICALS For: Feb 27 Filed by: McKee Amy E
3/2
03:16 pm
bcrx
Form 144 BIOCRYST PHARMACEUTICALS Filed by: Stonehouse Jon P
Low
Report
Form 144 BIOCRYST PHARMACEUTICALS Filed by: Stonehouse Jon P
2/26
04:05 pm
bcrx
Form 10-K BIOCRYST PHARMACEUTICALS For: Dec 31
High
Report
Form 10-K BIOCRYST PHARMACEUTICALS For: Dec 31
2/26
07:20 am
bcrx
Form 8-K BIOCRYST PHARMACEUTICALS For: Feb 26
Low
Report
Form 8-K BIOCRYST PHARMACEUTICALS For: Feb 26
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/18
Form 4 BIOCRYST PHARMACEUTICALS For: Nov 18 Filed by: Babu Yarlagadda S
19.8%
3/3 Form 4 BIOCRYST PHARMACEUTICALS For: Feb 27 Filed by: LEVIN ALAN G 15.1%
5/29 Form SC 13G BIOCRYST PHARMACEUTICALS Filed by: INTEGRATED CORE STRATEGIES (US) LLC 14.7%
4/9 BioCryst Begins Clinical Trial with Galidesivir for Treatment of Patients with COVID-19 13.5%
9/23 BioCryst Appoints Helen Thackray, M.D., to Board of Directors 12.9%
2/25 Form 4 BIOCRYST PHARMACEUTICALS For: Feb 21 Filed by: Jones Michael L 11.9%
3/13 BioCryst Pharmaceuticals: Multiple Value Drivers With A Coronavirus Kicker [Seeking Alpha] 11.9%
1/26 5 Biotech Stocks to Watch With the Coronavirus Scare [The Motley Fool] 11.1%
3/19 BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 11.0%
4/23 BioCryst feels Gilead's remdesivir pain, down 9% [Seeking Alpha] 10.6%
3/3 Form 4 BIOCRYST PHARMACEUTICALS For: Feb 27 Filed by: LEVIN ALAN G 15.1%
5/29 Form SC 13G BIOCRYST PHARMACEUTICALS Filed by: INTEGRATED CORE STRATEGIES (US) LLC 14.7%
4/9 BioCryst Begins Clinical Trial with Galidesivir for Treatment of Patients with COVID-19 13.5%
9/23 BioCryst Appoints Helen Thackray, M.D., to Board of Directors 12.9%
2/25 Form 4 BIOCRYST PHARMACEUTICALS For: Feb 21 Filed by: Jones Michael L 11.9%
3/13 BioCryst Pharmaceuticals: Multiple Value Drivers With A Coronavirus Kicker [Seeking Alpha] 11.9%
1/26 5 Biotech Stocks to Watch With the Coronavirus Scare [The Motley Fool] 11.1%
3/19 BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 11.0%
4/23 BioCryst feels Gilead's remdesivir pain, down 9% [Seeking Alpha] 10.6%
TOP News Decliners
5/20
Form 4 BIOCRYST PHARMACEUTICALS For: May 16 Filed by: STAAB THOMAS R II
-52.9%
3/9 BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC. -34.2%
3/10 Form 8-K BIOCRYST PHARMACEUTICALS For: Mar 04 -23.2%
3/16 BEROTRALSTAT (BCX7353) SIGNIFICANTLY REDUCED USE OF ACUTE ON-DEMAND MEDICINE IN HAE PATIENTS IN APEX-2 -19.7%
4/9 BioCryst stock rallies on start of coronavirus drug study [MarketWatch] -19.0%
12/11 Form 8-K BIOCRYST PHARMACEUTICALS For: Dec 11 -10.4%
1/12 BioCryst to Provide Berotralstat and BCX9930 Program Updates at 38th Annual J.P. Morgan Healthcare Conference -10.1%
1/27 Why BioCryst Pharmaceuticals Stock Is Jumping Again Today [The Motley Fool] -10.0%
2/25 BioCryst Appoints Alan G. Levin to Board of Directors -9.4%
5/24 Form 4 BIOCRYST PHARMACEUTICALS For: May 22 Filed by: ASELAGE STEVE -9.2%
3/9 BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC. -34.2%
3/10 Form 8-K BIOCRYST PHARMACEUTICALS For: Mar 04 -23.2%
3/16 BEROTRALSTAT (BCX7353) SIGNIFICANTLY REDUCED USE OF ACUTE ON-DEMAND MEDICINE IN HAE PATIENTS IN APEX-2 -19.7%
4/9 BioCryst stock rallies on start of coronavirus drug study [MarketWatch] -19.0%
12/11 Form 8-K BIOCRYST PHARMACEUTICALS For: Dec 11 -10.4%
1/12 BioCryst to Provide Berotralstat and BCX9930 Program Updates at 38th Annual J.P. Morgan Healthcare Conference -10.1%
1/27 Why BioCryst Pharmaceuticals Stock Is Jumping Again Today [The Motley Fool] -10.0%
2/25 BioCryst Appoints Alan G. Levin to Board of Directors -9.4%
5/24 Form 4 BIOCRYST PHARMACEUTICALS For: May 22 Filed by: ASELAGE STEVE -9.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: